ADAR1 Capital Management’s Achieve Life Sciences ACHV Stock Holding History

ADAR1 Capital Management’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$351K	Buy	53,800 +6,000	+13%	+$28.6K	0.02%	228
2026 Q1	$141K	Hold	47,800	–	–	0.01%	277
2025 Q4	$238K	Hold	47,800	–	–	0.02%	225
2025 Q3	$151K	Buy	47,800 +4,627	+11%	+$12.7K	0.01%	190
2025 Q2	$97.6K	Hold	43,173	–	–	0.02%	176
2025 Q1	$115K	Buy	43,173 +30,000	+228%	+$93.3K	0.02%	160
2024 Q4	$46.4K	Buy	13,173 +13,082	+14,376%	+$59.3K	0.01%	194
2024 Q3	$431	Sell	91 -542,142	-100%	-$2.48M	﹤0.01%	275
2024 Q2	$2.55M	Sell	542,233 -332,767	-38%	-$1.6M	0.48%	38
2024 Q1	$3.98M	Buy	+875,000	New	+$3.88M	0.9%	21

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

ADAR1 Capital Management's ACHV Position: Q2 2026 in Review

ADAR1 Capital Management increased its Achieve Life Sciences (ACHV) stake by 13% in Q2 2026, buying an estimated $28.6K and bringing the position to 53,800 shares worth $351K. The position accounts for 0.02% of the portfolio, ranked #228.

ADAR1 Capital Management first reported a position in ACHV in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.98M in Q1 2024. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

ADAR1 Capital Management held 53,800 shares of Achieve Life Sciences worth $351K as of Q2 2026.
ADAR1 Capital Management bought 6,000 Achieve Life Sciences shares in Q2 2026, an estimated $28.6K.
Achieve Life Sciences made up 0.02% of ADAR1 Capital Management's portfolio in Q2 2026, its #228 holding.
ADAR1 Capital Management first reported a position in Achieve Life Sciences in Q1 2024 and has held it in 10 quarters since.
ADAR1 Capital Management's Achieve Life Sciences position peaked at $3.98M in Q1 2024.
111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.